Listed

Mustang Bio, Inc.

MBIONasdaqCIK 1680048HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$1.2m, Q2 FY2026
Net income−$1.1m, Q2 FY2026
Mustang Bio, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(10.3)Operating income, Q3 FY2023, three months to 2023-09-30−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figure(8.7)Operating income, Q4 FY2023, three months to 2023-12-31−$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-28, accession 0001558370-25-003913. Derived: 12-month figure less the 9-month figure.Report this figure(5.2)Operating income, Q1 FY2024, three months to 2024-03-31−$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure(8.5)Operating income, Q2 FY2024, three months to 2024-06-30−$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure(1.5)Operating income, Q3 FY2024, three months to 2024-09-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure(1.0)Operating income, Q4 FY2024, three months to 2024-12-31−$1.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-032063. Derived: 12-month figure less the 9-month figure.Report this figure(0.3)Operating income, Q1 FY2025, three months to 2025-03-31−$253.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure(0.9)Operating income, Q2 FY2025, three months to 2025-06-30−$885.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure(0.6)Operating income, Q3 FY2025, three months to 2025-09-30−$624.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure(0.7)Operating income, Q4 FY2025, three months to 2025-12-31−$670.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-032063. Derived: 12-month figure less the 9-month figure.Report this figure(1.1)Operating income, Q1 FY2026, three months to 2026-03-31−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure(1.2)Operating income, Q2 FY2026, three months to 2026-06-30−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure
Net income$m(10.1)Net income, Q3 FY2023, three months to 2023-09-30−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figure(8.6)Net income, Q4 FY2023, three months to 2023-12-31−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-28, accession 0001558370-25-003913. Derived: 12-month figure less the 9-month figure.Report this figure(5.2)Net income, Q1 FY2024, three months to 2024-03-31−$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure(8.2)Net income, Q2 FY2024, three months to 2024-06-30−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure(1.4)Net income, Q3 FY2024, three months to 2024-09-30−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure(1.0)Net income, Q4 FY2024, three months to 2024-12-31−$952.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-032063. Derived: 12-month figure less the 9-month figure.Report this figure(0.2)Net income, Q1 FY2025, three months to 2025-03-31−$153.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure(0.8)Net income, Q2 FY2025, three months to 2025-06-30−$762.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure(0.5)Net income, Q3 FY2025, three months to 2025-09-30−$468.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure(0.5)Net income, Q4 FY2025, three months to 2025-12-31−$538.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001104659-26-032063. Derived: 12-month figure less the 9-month figure.Report this figure(1.0)Net income, Q1 FY2026, three months to 2026-03-31−$955.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure(1.1)Net income, Q2 FY2026, three months to 2026-06-30−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure
Diluted EPS$ per share(1.23)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figurenot reported(24.81)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$24.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure(18.36)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$18.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure(1.96)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figurenot reported(0.05)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure(0.19)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure(0.07)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figurenot reported(0.14)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure(0.16)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure
Basic EPS$ per share(1.23)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figurenot reported(24.81)Basic EPS, Q1 FY2024, three months to 2024-03-31−$24.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure(18.36)Basic EPS, Q2 FY2024, three months to 2024-06-30−$18.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure(1.96)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figurenot reported(0.05)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure(0.19)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure(0.07)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figurenot reported(0.14)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure(0.16)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure

Balance sheet

Cash and equivalents$15.2m, Q2 FY2026
Shareholders' equity$7.5m, Q2 FY2026
Mustang Bio, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m9.6Cash and equivalents, Q3 FY2023, at 2023-09-30$9.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figure6.2Cash and equivalents, FY2023, at 2023-12-31$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-28, accession 0001558370-25-003913.Report this figure1.3Cash and equivalents, Q1 FY2024, at 2024-03-31$1.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001558370-24-008283.Report this figure4.3Cash and equivalents, Q2 FY2024, at 2024-06-30$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001558370-24-012051.Report this figure3.5Cash and equivalents, Q3 FY2024, at 2024-09-30$3.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figure6.8Cash and equivalents, FY2024, at 2024-12-31$6.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001104659-26-032063.Report this figure14.2Cash and equivalents, Q1 FY2025, at 2025-03-31$14.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure12.7Cash and equivalents, Q2 FY2025, at 2025-06-30$12.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure19.0Cash and equivalents, Q3 FY2025, at 2025-09-30$19.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure17.3Cash and equivalents, FY2025, at 2025-12-31$17.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure16.3Cash and equivalents, Q1 FY2026, at 2026-03-31$16.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure15.2Cash and equivalents, Q2 FY2026, at 2026-06-30$15.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure
Current assets$m13.6Current assets, Q3 FY2023, at 2023-09-30$13.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019010.Report this figure11.3Current assets, FY2023, at 2023-12-31$11.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-28, accession 0001558370-25-003913.Report this figure9.2Current assets, Q1 FY2024, at 2024-03-31$9.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001558370-24-008283.Report this figure7.3Current assets, Q2 FY2024, at 2024-06-30$7.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001558370-24-012051.Report this figure6.1Current assets, Q3 FY2024, at 2024-09-30$6.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figure8.6Current assets, FY2024, at 2024-12-31$8.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001104659-26-032063.Report this figure14.9Current assets, Q1 FY2025, at 2025-03-31$14.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure13.0Current assets, Q2 FY2025, at 2025-06-30$13.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure19.4Current assets, Q3 FY2025, at 2025-09-30$19.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure17.6Current assets, FY2025, at 2025-12-31$17.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001104659-26-032063.Report this figurenot reportednot reported
Total assets$m20.6Total assets, Q3 FY2023, at 2023-09-30$20.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001558370-23-019010.Report this figure17.7Total assets, FY2023, at 2023-12-31$17.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-28, accession 0001558370-25-003913.Report this figure14.6Total assets, Q1 FY2024, at 2024-03-31$14.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001558370-24-008283.Report this figure8.5Total assets, Q2 FY2024, at 2024-06-30$8.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001558370-24-012051.Report this figure7.2Total assets, Q3 FY2024, at 2024-09-30$7.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figure9.3Total assets, FY2024, at 2024-12-31$9.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001104659-26-032063.Report this figure14.9Total assets, Q1 FY2025, at 2025-03-31$14.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure13.0Total assets, Q2 FY2025, at 2025-06-30$13.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure19.4Total assets, Q3 FY2025, at 2025-09-30$19.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure17.6Total assets, FY2025, at 2025-12-31$17.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure16.6Total assets, Q1 FY2026, at 2026-03-31$16.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure15.6Total assets, Q2 FY2026, at 2026-06-30$15.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure
Current liabilities$m14.2Current liabilities, Q3 FY2023, at 2023-09-30$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019010.Report this figure15.4Current liabilities, FY2023, at 2023-12-31$15.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-28, accession 0001558370-25-003913.Report this figure17.4Current liabilities, Q1 FY2024, at 2024-03-31$17.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001558370-24-008283.Report this figure15.9Current liabilities, Q2 FY2024, at 2024-06-30$15.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001558370-24-012051.Report this figure15.0Current liabilities, Q3 FY2024, at 2024-09-30$15.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figure12.6Current liabilities, FY2024, at 2024-12-31$12.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001104659-26-032063.Report this figure11.2Current liabilities, Q1 FY2025, at 2025-03-31$11.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure10.0Current liabilities, Q2 FY2025, at 2025-06-30$10.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure9.4Current liabilities, Q3 FY2025, at 2025-09-30$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure7.9Current liabilities, FY2025, at 2025-12-31$7.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure7.8Current liabilities, Q1 FY2026, at 2026-03-31$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure7.9Current liabilities, Q2 FY2026, at 2026-06-30$7.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure
Total liabilities$m16.6Total liabilities, Q3 FY2023, at 2023-09-30$16.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001558370-23-019010.Report this figure17.6Total liabilities, FY2023, at 2023-12-31$17.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-28, accession 0001558370-25-003913.Report this figure19.5Total liabilities, Q1 FY2024, at 2024-03-31$19.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001558370-24-008283.Report this figure16.8Total liabilities, Q2 FY2024, at 2024-06-30$16.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001558370-24-012051.Report this figure15.8Total liabilities, Q3 FY2024, at 2024-09-30$15.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figure13.2Total liabilities, FY2024, at 2024-12-31$13.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001104659-26-032063.Report this figure11.3Total liabilities, Q1 FY2025, at 2025-03-31$11.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure10.2Total liabilities, Q2 FY2025, at 2025-06-30$10.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure9.6Total liabilities, Q3 FY2025, at 2025-09-30$9.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure8.1Total liabilities, FY2025, at 2025-12-31$8.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure8.0Total liabilities, Q1 FY2026, at 2026-03-31$8.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure8.1Total liabilities, Q2 FY2026, at 2026-06-30$8.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m4.0Shareholders' equity, Q3 FY2023, at 2023-09-30$4.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figure0.1Shareholders' equity, FY2023, at 2023-12-31$123.0k. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001104659-26-032063.Report this figure(4.9)Shareholders' equity, Q1 FY2024, at 2024-03-31−$4.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure(8.3)Shareholders' equity, Q2 FY2024, at 2024-06-30−$8.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure(8.7)Shareholders' equity, Q3 FY2024, at 2024-09-30−$8.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure(3.9)Shareholders' equity, FY2024, at 2024-12-31−$3.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure3.6Shareholders' equity, Q1 FY2025, at 2025-03-31$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure2.9Shareholders' equity, Q2 FY2025, at 2025-06-30$2.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure9.8Shareholders' equity, Q3 FY2025, at 2025-09-30$9.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure9.5Shareholders' equity, FY2025, at 2025-12-31$9.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure8.6Shareholders' equity, Q1 FY2026, at 2026-03-31$8.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure7.5Shareholders' equity, Q2 FY2026, at 2026-06-30$7.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure

Cash flow

Operating cash flow−$967.0k, Q2 FY2026
Capital expenditure$0, Q4 FY2024
Mustang Bio, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(12.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001558370-24-015048. Derived: 9-month figure less the 6-month figure.Report this figure(7.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-28, accession 0001558370-25-003913. Derived: 12-month figure less the 9-month figure.Report this figure(5.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure(2.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001558370-25-010920. Derived: 6-month figure less the 3-month figure.Report this figure(1.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001104659-25-108468. Derived: 9-month figure less the 6-month figure.Report this figure(2.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001104659-26-032063. Derived: 12-month figure less the 9-month figure.Report this figure(1.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure(1.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001104659-26-091061. Derived: 6-month figure less the 3-month figure.Report this figure(0.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$818.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001104659-25-108468. Derived: 9-month figure less the 6-month figure.Report this figure(1.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001104659-26-032063. Derived: 12-month figure less the 9-month figure.Report this figure(1.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$1.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure(1.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$967.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001104659-26-091061. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-08, accession 0001558370-24-015048. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$30.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-28, accession 0001558370-25-003913. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-08, accession 0001558370-24-015048. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-28, accession 0001558370-25-003913. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)6.73m, Q2 FY2026
Mustang Bio, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)k shares7,850Diluted shares (weighted), Q3 FY2022, three months to 2022-09-307,850,208 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001558370-23-019010.Report this figure8,094Diluted shares (weighted), Q1 FY2023, three months to 2023-03-318,093,662 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001558370-24-008283.Report this figure8,127Diluted shares (weighted), Q2 FY2023, three months to 2023-06-308,127,473 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001558370-24-012051.Report this figure8,172Diluted shares (weighted), Q3 FY2023, three months to 2023-09-308,171,582 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-08, accession 0001558370-24-015048.Report this figure209Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31209,201 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001558370-25-007736.Report this figure447Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30446,587 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001558370-25-010920.Report this figure721Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30720,911 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure2,861Diluted shares (weighted), Q1 FY2025, three months to 2025-03-312,860,946 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure4,021Diluted shares (weighted), Q2 FY2025, three months to 2025-06-304,021,276 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure6,242Diluted shares (weighted), Q3 FY2025, three months to 2025-09-306,241,658 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001104659-25-108468.Report this figure6,730Diluted shares (weighted), Q1 FY2026, three months to 2026-03-316,729,855 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001104659-26-055598.Report this figure6,733Diluted shares (weighted), Q2 FY2026, three months to 2026-06-306,732,970 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001104659-26-091061.Report this figure

Shares outstanding: 24.98mShares outstanding, Q1 FY2017, at 2017-03-3024,976,289 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2017-03-31, accession 0001144204-17-017831.Report this figure at Mar 30, 2017, from the cover of the 10-K filed Mar 31, 2017.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.